Cargando…
Therapeutic-Dose Warfarin (International Normalized Ratio >1.6) Plus Aspirin Improved Long-Term Patency of Saphenous Vein Graft without Bleeding Complication
Purpose: Saphenous vein graft (SVG) is the most commonly used conduits in coronary artery bypass grafting (CABG), but the disadvantage of SVG is its tendency for progressive failure. We hypothesized that therapeutic-dose warfarin (international normalized ratio [INR] >1.6) plus aspirin improve SV...
Autores principales: | Tasaki, Dai, Arai, Hirokuni, Yokoyama, Kenji, Yoshizaki, Tomoya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Editorial Committee of Annals of Thoracic and Cardiovascular Surgery
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8915932/ https://www.ncbi.nlm.nih.gov/pubmed/35034937 http://dx.doi.org/10.5761/atcs.oa.21-00236 |
Ejemplares similares
-
Graft Patency of No-Touch Saphenous Veins Used as Aortocoronary Bypass Grafts
por: Kim, Jeongwon, et al.
Publicado: (2023) -
Impacts of Intraoperative Flow on Graft Patency of Sequential and Individual Saphenous Vein Grafts
por: Takazawa, Akitoshi, et al.
Publicado: (2015) -
About the saphenous vein graft patencies after coronary artery bypass surgery
por: Çakır, Habib, et al.
Publicado: (2019) -
Expandable external support device to improve Saphenous Vein Graft Patency after CABG
por: Ben-Gal, Yanai, et al.
Publicado: (2013) -
Novel no touch technique of saphenous vein harvesting: Is great graft patency rate provided?
por: Papakonstantinou, Nikolaos A., et al.
Publicado: (2016)